MICB and neoplasm: Tumors evade γδT cell-mediated cytotoxicity through several mechanisms, including the downregulation of NKG2D ligands (e.g., MICA, MICB, ULBPs), which are crucial for γδT cells to efficiently recognize and attack tumor cells (82).